Directed new share issue in IRRAS AB (SE) — SEK 106 million

Carnegie acted as global co-ordinator in the directed new share issue of 4,800,000 shares at a subscription price of SEK 22 per share. IRRAS is a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions for brain surgery. May 2019.